These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 1370430)

  • 1. Characterization of an 18,000-molecular-weight outer membrane protein of Haemophilus ducreyi that contains a conserved surface-exposed epitope.
    Spinola SM; Griffiths GE; Bogdan J; Menegus MA
    Infect Immun; 1992 Feb; 60(2):385-91. PubMed ID: 1370430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The conserved 18,000-molecular-weight outer membrane protein of Haemophilus ducreyi has homology to PAL.
    Spinola SM; Hiltke TJ; Fortney K; Shanks KL
    Infect Immun; 1996 Jun; 64(6):1950-5. PubMed ID: 8675292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of a surface-exposed, conformational epitope of the P6 protein of Haemophilus influenzae.
    Bogdan JA; Apicella MA
    Infect Immun; 1995 Nov; 63(11):4395-401. PubMed ID: 7591076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The major outer membrane protein of Haemophilus ducreyi is a member of the OmpA family of proteins.
    Spinola SM; Griffiths GE; Shanks KL; Blake MS
    Infect Immun; 1993 Apr; 61(4):1346-51. PubMed ID: 8454337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structurally defined epitopes of Haemophilus ducreyi lipooligosaccharides recognized by monoclonal antibodies.
    Ahmed HJ; Frisk A; Månsson JE; Schweda EK; Lagergård T
    Infect Immun; 1997 Aug; 65(8):3151-8. PubMed ID: 9234768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining Potential Vaccine Targets of Haemophilus ducreyi Trimeric Autotransporter Adhesin DsrA.
    Fusco WG; Choudhary NR; Stewart SM; Alam SM; Sempowski GD; Elkins C; Leduc I
    Monoclon Antib Immunodiagn Immunother; 2015 Apr; 34(2):73-82. PubMed ID: 25897604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a rapid immunodiagnostic test for Haemophilus ducreyi.
    Patterson K; Olsen B; Thomas C; Norn D; Tam M; Elkins C
    J Clin Microbiol; 2002 Oct; 40(10):3694-702. PubMed ID: 12354868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies specific to surface antigens are not effective in complement-mediated killing of Haemophilus ducreyi.
    Frisk A; Ahmed HJ; Van Dyck E; Lagergård T
    Microb Pathog; 1998 Aug; 25(2):67-75. PubMed ID: 9712686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies directed against Haemophilus ducreyi heat shock proteins.
    Brown TJ; Jardine J; Ison CA
    Microb Pathog; 1993 Aug; 15(2):131-9. PubMed ID: 8255206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies against Haemophilus lipopolysaccharides: clone DP8 specific for Haemophilus ducreyi and clone DH24 binding to lacto-N-neotetraose.
    Borrelli S; Roggen EL; Hendriksen D; Jonasson J; Ahmed HJ; Piot P; Jansson PE; Lindberg AA
    Infect Immun; 1995 Jul; 63(7):2665-73. PubMed ID: 7790083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immune response of humans to lipooligosaccharide and outer membrane proteins of Haemophilus ducreyi.
    Alfa MJ; Olson N; Degagne P; Plummer F; Namaara W; Maclean I; Ronald AR
    J Infect Dis; 1993 May; 167(5):1206-10. PubMed ID: 8486955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of an immunoreactive 17.5-kilodalton outer membrane protein of Haemophilus somnus by using a monoclonal antibody.
    Tagawa Y; Haritani M; Yuasa N
    Infect Immun; 1993 Oct; 61(10):4153-7. PubMed ID: 7691744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of monoclonal antibodies specific for Haemophilus ducreyi: a screening method to discriminate specific and cross-reacting antibodies.
    Odumeru JA; Alfa MJ; Martin CF; Ronald AR; Jay FT
    Hybridoma; 1989 Jun; 8(3):337-51. PubMed ID: 2787274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a heat-modifiable outer membrane protein of Haemophilus somnus.
    Tagawa Y; Haritani M; Ishikawa H; Yuasa N
    Infect Immun; 1993 May; 61(5):1750-5. PubMed ID: 8478064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of dot-immunobinding and immunofluorescence assays to investigate clinically suspected cases of chancroid.
    Schalla WO; Sanders LL; Schmid GP; Tam MR; Morse SA
    J Infect Dis; 1986 May; 153(5):879-87. PubMed ID: 3517183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a novel lipoprotein expressed by Haemophilus ducreyi.
    Hiltke TJ; Campagnari AA; Spinola SM
    Infect Immun; 1996 Dec; 64(12):5047-52. PubMed ID: 8945545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of highly conserved and species-specific polypeptides of Haemophilus ducreyi.
    Alfa MJ; Yang CL; Slaney LA; Kwok AY; Ronald AR; Jay FT
    J Med Microbiol; 1992 Dec; 37(6):413-9. PubMed ID: 1281234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outer membrane protein P4 is not required for virulence in the human challenge model of Haemophilus ducreyi infection.
    Janowicz DM; Zwickl BW; Fortney KR; Katz BP; Bauer ME
    BMC Microbiol; 2014 Jun; 14():166. PubMed ID: 24961160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a serological test for Haemophilus ducreyi for seroprevalence studies.
    Elkins C; Yi K; Olsen B; Thomas C; Thomas K; Morse S
    J Clin Microbiol; 2000 Apr; 38(4):1520-6. PubMed ID: 10747137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Haemophilus ducreyi lipooligosaccharide by means of an immunolimulus assay.
    Hansen EJ; Lumbley SR; Saxen H; Kern K; Cope LD; Radolf JD
    J Immunol Methods; 1995 Sep; 185(2):225-35. PubMed ID: 7561133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.